Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the sy...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 8 6555 2950
Fax: 61 8 6166 0261
Address:
295 Rokeby Road, Suite 1, Subiaco, Australia
